RxDoctor Payments Data

Nathan Stroble

Psychiatric/Mental Health · Toledo, OHNPI 1306354576

Payments from drug & device makers

$2,561in general payments, 2019–2025

Across 142 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$497
  • Otsuka America Pharmaceutical, Inc.$443
  • Alkermes, Inc.$319
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$313
  • Indivior Inc.$214
  • Teva Pharmaceuticals USA, Inc.$182
  • plus $592 from 7 others

What the payments were for

  • Food & beverage$2,52499%
  • Education$371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,561 in reported general payments places this provider in the 80th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$7,401
Medicare patients
29
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate53$173,828
RexultiBrexpiprazole40$57,037
Abilify MaintenaAripiprazole19$55,612
VraylarCariprazine Hcl15$21,187
TrintellixVortioxetine Hydrobromide39$18,522
Aripiprazole145$17,870
Quetiapine Fumarate ErQuetiapine Fumarate63$6,865
Paliperidone ErPaliperidone25$4,612
Lurasidone Hcl48$4,441
Clozapine39$3,155
Olanzapine80$2,397
Quetiapine Fumarate134$1,829
Risperidone164$1,495
Hydroxyzine Hcl91$1,347
Oxcarbazepine45$1,345

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$137$173,82853 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$443$112,64859 claims
AbbVieVraylar$497$21,18715 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$32$18,52239 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →